fusidic acid has been researched along with mupirocin in 57 studies
Studies (fusidic acid) | Trials (fusidic acid) | Recent Studies (post-2010) (fusidic acid) | Studies (mupirocin) | Trials (mupirocin) | Recent Studies (post-2010) (mupirocin) |
---|---|---|---|---|---|
1,742 | 117 | 344 | 1,401 | 214 | 567 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (7.02) | 18.7374 |
1990's | 7 (12.28) | 18.2507 |
2000's | 16 (28.07) | 29.6817 |
2010's | 24 (42.11) | 24.3611 |
2020's | 6 (10.53) | 2.80 |
Authors | Studies |
---|---|
Andersson, DI; Maisnier-Patin, S; Paulander, W; Pennhag, A | 1 |
Bryce, E; Gravel, D; Loeb, M; Louie, L; Matlow, A; McGeer, A; Mulvey, M; Ofner-Agostini, M; Simor, AE; Stuart, TL; Watt, C | 1 |
Apajalahti, J; Fox, J; Frimodt-Møller, N; Hansen, F; Loidl, G; Nagai, J; Siikanen, O; Takano, M; Vaara, M; Vaara, T | 1 |
Boyd, EA; Brown, D; Collins, I; Czaplewski, LG; East, SP; Fletcher, R; Gardiner, M; Haydon, DJ; Henstock, V; Ingram, P; Jones, C; Kennison, L; Noula, C; Rockley, C; Rose, V; Stokes, NR; Thomaides-Brears, HB; Ure, R; Whittaker, M | 1 |
Bavari, S; Bowlin, TL; Houseweart, C; Moir, DT; Opperman, TJ; Panchal, RG; Peet, NP; Williams, JD | 1 |
Apajalahti, J; Fox, J; Frimodt-Møller, N; He, H; Li, J; Nation, RL; Poudyal, A; Siikanen, O; Vaara, M; Vaara, T | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Brozovic, A; Dowson, CG; Gazvoda, M; Košmrlj, J; Lloyd, A; Osmak, M; Proud, C; Roper, DI; Vajs, J | 1 |
Ashenden, S; Bender, A; Cokol, M; Karakoc, I; Kuru, N; Mason, DJ; Meral, S; Stott, I; Weinstein, ZB | 1 |
Johnston, C | 1 |
Collins, PO; Rowsell, RB; White, DG | 1 |
Gilbert, M | 1 |
Gernhardt, P; Klein, A; Possot, O; Sibold, L | 1 |
Morley, PA; Munot, LD | 1 |
Blázquez, MJ; Bouza, E; Cercenado, E; Guerrero, MC; Menarguez, MC; Moreno, S; Parras, F | 1 |
Ambler, JE; Drabu, YJ | 1 |
Pulverer, G; Schierholz, JM | 2 |
Beuth, J; Pulverer, G; Schierholz, JM | 1 |
Livingstone, V; Stringer, LJ | 1 |
Bryant, J; Gisby, J | 1 |
Afset, JE; Maeland, JA | 1 |
Coates, P; Cove, JH; Eady, EA; Layton, AM; Murtagh, MS; Ravenscroft, JC; Walker, M | 1 |
George, A; Rubin, G | 1 |
Chopra, I; Hurdle, JG; O'Neill, AJ | 1 |
Johnston, GA; Sladden, MJ | 1 |
Caldwell, F; Kreiswirth, BN; Low, DE; McGeer, A; Rousseau, J; Weese, JS; Willey, BM | 1 |
Mazereeuw-Hautier, J | 1 |
Afzal-Shah, M; Livermore, DM; Warner, M; Woodford, N | 1 |
Baines, SJ; Edwards, EA; Felmingham, D; Lloyd, DH; Loeffler, A; Milsom, SK; Toleman, MS | 1 |
Cohen, R; Gillet, Y; Moulin, F; Quinet, B; Raymond, J | 1 |
Brown, M; Kong, F; Liu, Y; Ma, L; Yang, Y; Zhang, X | 1 |
Chu Sing Lim, L; Sakharkar, KR; Sakharkar, MK; Soe, WM; Tzer Pin Lin, R | 1 |
Farrell, DJ; Love, WG; Rhys-Williams, W; Robbins, M | 1 |
Berger, M; Butler, CC; Koning, S; Morris, AD; van der Sande, R; van der Wouden, JC; van Suijlekom-Smit, LW; Verhagen, AP | 1 |
Campos, R; Gómez-González, MC; Lancho, JM; Marigliano, N; Pascua, J; Teno, P | 1 |
Anderson, M; D'Lima, L; Debabov, D; Friedman, L; Wang, L; Xu, P | 1 |
Crepinsek, MA; Crowe, L; Michener, K; Smart, NA | 1 |
Del Rosario-Quintana, C; Dorta-Hung, E; Martín-Sánchez, AM; Molina-Cabrillana, J; Quori, A; Tosco-Núñez, T | 1 |
Champion, EA; Hobbs, MM; Miller, MB; Muhlebach, MS; Popowitch, EB; Saiman, L | 1 |
Frimodt-Møller, N; Vingsbo Lundberg, C | 1 |
Lanier, J; Qui, MK; Shim, J | 1 |
Gómez-Recuero-Muñoz, L; Lozano-Masdemont, B; Pulido-Pérez, A | 1 |
Kilic, K; Sakat, MS; Ucuncu, H | 1 |
Ahn, JW; Baek, YS; Jeon, J; Song, HJ | 1 |
Abushahba, MF; Mohammad, H; Seleem, MN; Sobreira, TJ; Thangamani, S | 1 |
Best, E; Leversha, A; Ritchie, SR; Smith, A; Thomas, MG; Upton, A; Williamson, D | 1 |
Baines, SL; Carter, GP; Gonçalves da Silva, A; Heffernan, H; Howden, BP; Monk, IR; Pham, PH; Schultz, MB; Stinear, TP; Tiong, A; Williamson, DA | 1 |
Bogdan, C; Kiefer, A; Melichar, VO | 1 |
Yu, X; Zheng, H | 1 |
Doudoulakakis, A; Giormezis, N; Lebessi, E; Militsopoulou, M; Spiliopoulou, I; Syridou, G; Tsolia, M | 1 |
Chen, W; Cui, Z; He, C; Liu, Q; Shu, W; Tang, R; Yang, H; Zhang, C | 1 |
Crepinsek, MA; Michener, K; Stewart, F; Taylor, EA | 1 |
Brown, M; Dempsey, K; Kok, J; Li, C; Nahidi, S; O'Sullivan, MVN; Ramsperger, M; Shaban, RZ; Sotomayor-Castillo, C | 1 |
Andriessen, A; Benjamin, LT; Claro, C; Eichenfield, LF; Esposito, SM; Keller, L; Kircik, L; Kwong, PC; McCuaig, C; Schachner, LA | 1 |
Adam, HJ; Baxter, M; Karlowsky, JA; Lagace-Wiens, PRS; Zhanel, GG | 1 |
Abdulamir, AS; Awni, AA; Hamed, ZO | 1 |
10 review(s) available for fusidic acid and mupirocin
Article | Year |
---|---|
A systematic review and meta-analysis of treatments for impetigo.
Topics: Administration, Topical; Adolescent; Algorithms; Child; Child, Preschool; Double-Blind Method; Drug Therapy, Combination; Erythromycin; Family Practice; Fusidic Acid; Humans; Impetigo; Infant; Infant, Newborn; Mupirocin; Randomized Controlled Trials as Topic; Treatment Outcome | 2003 |
Current options for the treatment of impetigo in children.
Topics: Anti-Bacterial Agents; Child; Drug Resistance, Bacterial; Erythromycin; Fusidic Acid; Humans; Impetigo; Infant; Mupirocin; Randomized Controlled Trials as Topic; Staphylococcal Scalded Skin Syndrome; Staphylococcus aureus; Streptococcus pyogenes | 2005 |
[Impetigo].
Topics: Administration, Oral; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Local; Azithromycin; Cephalosporins; Child; Clavulanic Acid; Clinical Trials as Topic; Diagnosis, Differential; Drug Therapy, Combination; Female; Fusidic Acid; Humans; Impetigo; Infant; Male; Methicillin; Mupirocin; Ointments; Penicillins; Pregnancy; Pristinamycin; Sulfadiazine; Time Factors | 2006 |
Interventions for impetigo.
Topics: Administration, Oral; Administration, Topical; Anti-Bacterial Agents; Erythromycin; Fusidic Acid; Humans; Impetigo; Mupirocin; Penicillins; Randomized Controlled Trials as Topic | 2012 |
Interventions for preventing mastitis after childbirth.
Topics: Anti-Bacterial Agents; Breast Feeding; Edible Grain; Female; Fusidic Acid; Humans; Mastitis; Mupirocin; Neuropeptides; Ointments; Patient Education as Topic; Randomized Controlled Trials as Topic | 2012 |
Clinical inquiry: what is the best treatment for impetigo ?
Topics: Administration, Topical; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents, Local; Bacitracin; Bridged Bicyclo Compounds, Heterocyclic; Cephalexin; Clindamycin; Cloxacillin; Dicloxacillin; Diterpenes; Erythromycin; Fusidic Acid; Gentamicins; Humans; Impetigo; Meta-Analysis as Topic; Mupirocin; Randomized Controlled Trials as Topic | 2014 |
Staphylococcus lugdunensis: An Emerging Pathogen in Skin and Soft Tissue Infections.
Topics: Abscess; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Communicable Diseases, Emerging; Female; Foot Diseases; Fusidic Acid; Humans; Insect Bites and Stings; Male; Middle Aged; Mupirocin; Soft Tissue Infections; Staphylococcal Skin Infections; Staphylococcus lugdunensis; Wound Infection | 2015 |
A bug in the ointment: topical antimicrobial usage and resistance in New Zealand.
Topics: Administration, Topical; Anti-Infective Agents; Drug Resistance, Multiple, Bacterial; Fusidic Acid; Humans; Methicillin-Resistant Staphylococcus aureus; Mupirocin; New Zealand | 2015 |
Interventions for preventing mastitis after childbirth.
Topics: Anti-Bacterial Agents; Bias; Breast Feeding; Edible Grain; Female; Fusidic Acid; Humans; Massage; Mastitis; Mupirocin; Neuropeptides; Ointments; Patient Education as Topic; Placebos; Probiotics; Randomized Controlled Trials as Topic | 2020 |
Do Antimicrobial Resistance Patterns Matter? An Algorithm for the Treatment of Patients With Impetigo.
Topics: Aminopyridines; Anti-Bacterial Agents; Antimicrobial Stewardship; Bridged Bicyclo Compounds, Heterocyclic; Critical Pathways; Delphi Technique; Diterpenes; Drug Resistance, Bacterial; Evidence-Based Medicine; Fusidic Acid; Humans; Impetigo; Microbial Sensitivity Tests; Mupirocin; Practice Guidelines as Topic; Quinolones; Skin Cream; Staphylococcus aureus; Streptococcus pyogenes; Systematic Reviews as Topic | 2021 |
7 trial(s) available for fusidic acid and mupirocin
Article | Year |
---|---|
Topical antibiotics in the treatment of superficial skin infections in general practice--a comparison of mupirocin with sodium fusidate.
Topics: Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Bacteria; Child; Child, Preschool; Fatty Acids; Fusidic Acid; Humans; Infant; Middle Aged; Multicenter Studies as Topic; Mupirocin; Random Allocation; Skin Diseases, Infectious; Staphylococcus aureus; Streptococcus | 1989 |
Topical 2% mupirocin versus 2% fusidic acid ointment in the treatment of primary and secondary skin infections.
Topics: Administration, Topical; Anti-Bacterial Agents; Bacterial Infections; Drug Evaluation; Fatty Acids; Female; Fusidic Acid; Humans; Male; Mupirocin; Ointments; Random Allocation; Skin Diseases, Infectious | 1989 |
A comparison of sodium fusidate ointment and mupirocin ointment in superficial skin sepsis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Fatty Acids; Female; Fusidic Acid; Humans; Impetigo; Infant; Male; Middle Aged; Mupirocin; Ointments; Skin Diseases, Infectious | 1988 |
Comparative study of mupirocin and oral co-trimoxazole plus topical fusidic acid in eradication of nasal carriage of methicillin-resistant Staphylococcus aureus.
Topics: Administration, Oral; Administration, Topical; Cross Infection; Drug Therapy, Combination; Female; Fusidic Acid; Humans; Male; Methicillin Resistance; Middle Aged; Mupirocin; Nasal Cavity; Prospective Studies; Staphylococcal Infections; Staphylococcus aureus; Trimethoprim, Sulfamethoxazole Drug Combination | 1995 |
The treatment of Staphyloccocus aureus infected sore nipples: a randomized comparative study.
Topics: Administration, Cutaneous; Administration, Oral; Anti-Bacterial Agents; Breast Diseases; Female; Fusidic Acid; Humans; Mupirocin; Nipples; Pain; Prospective Studies; Staphylococcal Skin Infections; Staphylococcus aureus | 1999 |
Short-term effects of topical fusidic acid or mupirocin on the prevalence of fusidic acid resistant (FusR) Staphylococcus aureus in atopic eczema.
Topics: Administration, Topical; Adolescent; Adult; Age Factors; Aged; Anti-Bacterial Agents; Carrier State; Chi-Square Distribution; Child; Child, Preschool; Dermatitis, Atopic; Drug Resistance, Microbial; Female; Fusidic Acid; Humans; Male; Middle Aged; Mupirocin; Sex Factors; Staphylococcus aureus; Statistics, Nonparametric; Time Factors; Treatment Outcome | 2003 |
Infections after photodynamic therapy in Condyloma acuminatum patients: incidence and management.
Topics: Adolescent; Adult; Aminolevulinic Acid; Anti-Bacterial Agents; Bacterial Infections; Beijing; Condylomata Acuminata; Female; Fusidic Acid; Genital Diseases, Female; Genital Diseases, Male; Humans; Incidence; Male; Middle Aged; Mupirocin; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Young Adult | 2018 |
40 other study(ies) available for fusidic acid and mupirocin
Article | Year |
---|---|
Caenorhabditis elegans as a model to determine fitness of antibiotic-resistant Salmonella enterica serovar typhimurium.
Topics: Animals; Caenorhabditis elegans; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Mice; Salmonella Infections, Animal; Salmonella typhimurium | 2007 |
Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals.
Topics: Aged; Anti-Bacterial Agents; Canada; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Hospitals; Humans; Male; Methicillin Resistance; Microbial Sensitivity Tests; Mupirocin; Staphylococcal Infections; Staphylococcus aureus | 2007 |
Novel polymyxin derivatives carrying only three positive charges are effective antibacterial agents.
Topics: Animals; Anti-Bacterial Agents; Cricetinae; Fibroblasts; Gram-Negative Bacteria; Kidney Cortex; Lung; Microbial Sensitivity Tests; Microvilli; Polymyxin B; Rats; Structure-Activity Relationship | 2008 |
Antibacterial alkoxybenzamide inhibitors of the essential bacterial cell division protein FtsZ.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Benzamides; Cytoskeletal Proteins; Microbial Sensitivity Tests; Staphylococcus; Structure-Activity Relationship | 2009 |
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
Topics: Bacterial Proteins; Drug Resistance, Bacterial; Indoles; Microbial Sensitivity Tests; Mutation; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Staphylococcus aureus; Structure-Activity Relationship; Substrate Specificity | 2010 |
A novel polymyxin derivative that lacks the fatty acid tail and carries only three positive charges has strong synergism with agents excluded by the intact outer membrane.
Topics: Animals; Anti-Bacterial Agents; Cell Membrane Permeability; Cricetinae; Cricetulus; Drug Synergism; Fibroblasts; Gram-Negative Bacteria; Guinea Pigs; Lung; Male; Microbial Sensitivity Tests; Polymyxin B; Rats; Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Diaryltriazenes as antibacterial agents against methicillin resistant Staphylococcus aureus (MRSA) and Mycobacterium smegmatis.
Topics: Anti-Bacterial Agents; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycobacterium smegmatis; Triazenes | 2017 |
Prediction of Antibiotic Interactions Using Descriptors Derived from Molecular Structure.
Topics: Anti-Bacterial Agents; Drug Interactions; Molecular Structure | 2017 |
Topical 2% mupirocin versus 2% sodium fusidate ointment in the treatment of primary and secondary skin infections.
Topics: Administration, Cutaneous; Anti-Bacterial Agents; Fatty Acids; Fusidic Acid; Humans; Impetigo; Mupirocin; Ointments | 1991 |
Analysis of drug resistance in the archaebacterium Methanococcus voltae with respect to potential use in genetic engineering.
Topics: Anti-Bacterial Agents; Culture Media; Drug Resistance, Microbial; Euryarchaeota; Fatty Acids; Fusidic Acid; Gene Expression Regulation; Genes, Bacterial; Methionine Sulfoximine; Mupirocin; Puromycin; R Factors; Transfection | 1988 |
Mupirocin-resistant methicillin-resistant Staphylococcus aureus.
Topics: Administration, Topical; Anti-Bacterial Agents; Bacitracin; Drug Interactions; Drug Resistance, Microbial; Fusidic Acid; Humans; Methicillin Resistance; Mupirocin; Polymyxin B; Staphylococcal Infections; Staphylococcus aureus | 1996 |
Development of a new CSF-shunt with sustained release of an antimicrobial broad-spectrum combination.
Topics: Bacteria; Bacterial Adhesion; Cerebrospinal Fluid Shunts; Delayed-Action Preparations; Drug Resistance, Microbial; Drug Therapy, Combination; Equipment Contamination; Fusidic Acid; Microbial Sensitivity Tests; Mupirocin; Rifampin; Silicones | 1997 |
Investigation of a rifampin, fusidic-acid and mupirocin releasing silicone catheter.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Bacterial Adhesion; Biocompatible Materials; Catheterization; Cerebrospinal Fluid Shunts; Delayed-Action Preparations; Erythrocytes; Fusidic Acid; Hemolysis; Humans; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Mupirocin; Rifampin; Silicones; Staphylococcus aureus; Staphylococcus epidermidis | 1998 |
Killing effects of antibiotics and two-fold antimicrobial combinations on proliferating and non growing staphylococci.
Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Erythromycin; Fusidic Acid; Humans; Microbial Sensitivity Tests; Mupirocin; Prostheses and Implants; Rifampin; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Staphylococcus epidermidis | 1998 |
Efficacy of a new cream formulation of mupirocin: comparison with oral and topical agents in experimental skin infections.
Topics: Administration, Oral; Administration, Topical; Animals; Anti-Bacterial Agents; Bacitracin; Cephalexin; Chemistry, Pharmaceutical; Cricetinae; Erythromycin; Female; Floxacillin; Fusidic Acid; Impetigo; Male; Mice; Mupirocin; Neomycin; Penicillins; Skin Diseases, Bacterial; Staphylococcal Infections; Staphylococcus; Streptococcal Infections; Streptococcus; Wound Infection | 2000 |
Susceptibility of skin and soft-tissue isolates of Staphylococcus aureus and Streptococcus pyogenes to topical antibiotics: indications of clonal spread of fusidic acid-resistant Staphylococcus aureus.
Topics: Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Bacitracin; Child; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Fusidic Acid; Genes, Bacterial; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mupirocin; Probability; Sensitivity and Specificity; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pyogenes | 2003 |
Anti-staphylococcal activity of indolmycin, a potential topical agent for control of staphylococcal infections.
Topics: Anti-Infective Agents, Local; Drug Resistance, Bacterial; Fusidic Acid; Geobacillus stearothermophilus; Indoles; Mupirocin; Staphylococcal Infections; Staphylococcus aureus; Tryptophan-tRNA Ligase | 2004 |
An outbreak of methicillin-resistant Staphylococcus aureus skin infections resulting from horse to human transmission in a veterinary hospital.
Topics: Adult; Animals; Animals, Newborn; Community-Acquired Infections; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Female; Fusidic Acid; Horse Diseases; Horses; Hospitals, Animal; Humans; Methicillin Resistance; Mupirocin; Rifampin; Staphylococcal Skin Infections; Staphylococcus aureus; Treatment Outcome; Zoonoses | 2006 |
In vitro activity of retapamulin against Staphylococcus aureus isolates resistant to fusidic acid and mupirocin.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bridged Bicyclo Compounds, Heterocyclic; Diterpenes; DNA Mutational Analysis; Drug Resistance, Bacterial; Fusidic Acid; Humans; Microbial Sensitivity Tests; Mupirocin; Ribosomal Protein L3; Ribosomal Proteins; Staphylococcal Infections; Staphylococcus aureus; United Kingdom | 2008 |
In vitro activity of fusidic acid and mupirocin against coagulase-positive staphylococci from pets.
Topics: Animals; Animals, Domestic; Anti-Bacterial Agents; Carrier State; Cats; Coagulase; Dogs; Fusidic Acid; Germany; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Mupirocin; Staphylococcal Infections; Staphylococcus; United Kingdom | 2008 |
[Managing children skin and soft tissue infections].
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cellulitis; Cephalosporins; Child; Drug Resistance, Bacterial; Fasciitis, Necrotizing; Furunculosis; Fusidic Acid; Humans; Impetigo; Injections, Intravenous; Macrolides; Methicillin-Resistant Staphylococcus aureus; Mupirocin; Penicillins; Pristinamycin; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Scalded Skin Syndrome; Staphylococcal Skin Infections; Staphylococcus aureus; Stevens-Johnson Syndrome; Streptococcal Infections; Streptococcus pyogenes | 2008 |
Antimicrobial susceptibility of Staphylococcus aureus isolated from children with impetigo in China from 2003 to 2007 shows community-associated methicillin-resistant Staphylococcus aureus to be uncommon and heterogeneous.
Topics: Anti-Bacterial Agents; Child; Child, Preschool; China; DNA, Bacterial; Female; Fusidic Acid; Humans; Impetigo; Infant; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mupirocin; Staphylococcal Skin Infections; Virulence Factors | 2009 |
In vitro drug interactions of gallates with antibiotics in Staphylococcus Aureus.
Topics: Anti-Bacterial Agents; Catechin; Drug Interactions; Fusidic Acid; Gallic Acid; In Vitro Techniques; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mupirocin; Tetracycline | 2010 |
Investigation of the potential for mutational resistance to XF-73, retapamulin, mupirocin, fusidic acid, daptomycin, and vancomycin in methicillin-resistant Staphylococcus aureus isolates during a 55-passage study.
Topics: Anti-Bacterial Agents; Bridged Bicyclo Compounds, Heterocyclic; Daptomycin; Diterpenes; Fusidic Acid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Mupirocin; Polymerase Chain Reaction; Porphyrins; Sequence Analysis, DNA; Vancomycin | 2011 |
[Colonization management of methicillin resistant Staphylococcus aureus in patients and health professional in the haemodialysis unit in a situation of high risk of endemic disease: looking for zero nasal carriers?].
Topics: Adult; Algorithms; Bacterial Load; Carrier State; Cross Infection; Disease Reservoirs; Endemic Diseases; Fusidic Acid; Hemodialysis Units, Hospital; Humans; Infection Control; Methicillin-Resistant Staphylococcus aureus; Mupirocin; Nasal Cavity; Patients; Personnel, Hospital; Prevalence; Risk; Staphylococcal Infections | 2012 |
No decrease in susceptibility to NVC-422 in multiple-passage studies with methicillin-resistant Staphylococcus aureus, S. aureus, Pseudomonas aeruginosa, and Escherichia coli.
Topics: Anti-Bacterial Agents; Bridged Bicyclo Compounds, Heterocyclic; Ciprofloxacin; Diterpenes; Drug Resistance, Multiple, Bacterial; Escherichia coli; Fusidic Acid; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mupirocin; Pseudomonas aeruginosa; Staphylococcus aureus; Taurine | 2012 |
[Antibiotic ointments and methicillin-resistant Staphylococcus aureus with a reservoir in a healthcare worker in a tertiary hospital].
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Carrier State; Cross Infection; Disease Outbreaks; Disease Reservoirs; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Fusidic Acid; Humans; Incidence; Infectious Disease Transmission, Professional-to-Patient; Male; Methicillin-Resistant Staphylococcus aureus; Mupirocin; Nasal Cavity; Nursing Assistants; Ointments; Personnel, Hospital; Retrospective Studies; Spain; Staphylococcal Infections; Tertiary Care Centers | 2013 |
Antimicrobial susceptibility and molecular typing of MRSA in cystic fibrosis.
Topics: Acetamides; Adolescent; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Bronchoscopy; Child; Child, Preschool; Cohort Studies; Cystic Fibrosis; DNA, Bacterial; Exotoxins; Female; Fosfomycin; Fusidic Acid; Humans; Leukocidins; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Molecular Typing; Mupirocin; Oxazolidinones; Penicillin-Binding Proteins; Pharynx; Pneumonia, Staphylococcal; Sequence Analysis, DNA; Sputum; Staphylococcal Infections; Staphylococcal Protein A; Tetracycline; Tigecycline; Trimethoprim, Sulfamethoxazole Drug Combination; United States | 2014 |
Efficacy of topical and systemic antibiotic treatment of meticillin-resistant Staphylococcus aureus in a murine superficial skin wound infection model.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Anti-Infective Agents, Local; Bacterial Load; Bridged Bicyclo Compounds, Heterocyclic; Diterpenes; Female; Fusidic Acid; Linezolid; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mupirocin; Oxazolidinones; Staphylococcal Skin Infections; Vancomycin; Wound Infection | 2013 |
Nasal Vestibular Furunculosis Presenting as the Rudolph Sign.
Topics: Administration, Intranasal; Administration, Oral; Animals; Anti-Bacterial Agents; Edema; Female; Furunculosis; Fusidic Acid; Humans; Middle Aged; Mupirocin; Nose Diseases; Staphylococcal Infections | 2015 |
Antimicrobial resistance of Staphylococcus aureus isolated from skin infections and its implications in various clinical conditions in Korea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Clindamycin; Dibekacin; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Fusidic Acid; Gentamicins; Humans; Infant; Infant, Newborn; Ketolides; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Mupirocin; Oxacillin; Republic of Korea; Retrospective Studies; Rifampin; Staphylococcal Skin Infections; Staphylococcus aureus; Teicoplanin; Tetracycline; Vancomycin; Virginiamycin; Young Adult | 2016 |
Repurposing auranofin for the treatment of cutaneous staphylococcal infections.
Topics: Animals; Anti-Bacterial Agents; Auranofin; Biofilms; Cell Line; Chemokine CCL2; Drug Repositioning; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Fusidic Acid; Humans; Interleukin-1beta; Interleukin-6; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mupirocin; Staphylococcal Skin Infections; Staphylococcus epidermidis; Tumor Necrosis Factor-alpha | 2016 |
Topical Antibiotic Use Coselects for the Carriage of Mobile Genetic Elements Conferring Resistance to Unrelated Antimicrobials in Staphylococcus aureus.
Topics: Administration, Topical; Anti-Bacterial Agents; Bayes Theorem; Drug Resistance, Multiple, Bacterial; Fusidic Acid; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Mupirocin; New Zealand; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus | 2018 |
Successful eradication of newly acquired MRSA in six of seven patients with cystic fibrosis applying a short-term local and systemic antibiotic scheme.
Topics: Administration, Inhalation; Administration, Intranasal; Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents, Local; Baths; Child; Child, Preschool; Cystic Fibrosis; Drug Therapy, Combination; Female; Fusidic Acid; Hand Disinfection; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Mupirocin; Retrospective Studies; Rifampin; Staphylococcal Infections; Treatment Outcome; Vancomycin; Young Adult | 2018 |
Emergence of staphylococcal scalded skin syndrome associated with a new toxinogenic, methicillin-susceptible Staphylococcus aureus clone.
Topics: Anti-Bacterial Agents; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Female; Fusidic Acid; Humans; Infant; Infant, Newborn; Male; Methicillin; Mupirocin; Staphylococcal Scalded Skin Syndrome; Staphylococcus aureus | 2019 |
Prevalence and molecular characterization of methicillin-resistant Staphylococcus aureus with mupirocin, fusidic acid and/or retapamulin resistance.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Bridged Bicyclo Compounds, Heterocyclic; China; Diterpenes; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Fusidic Acid; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Multilocus Sequence Typing; Mupirocin; Mutation; Prevalence; Sequence Analysis, DNA; Staphylococcal Infections | 2020 |
Outbreak of community-acquired Staphylococcus aureus skin infections in an Australian professional football team.
Topics: Administration, Intranasal; Anti-Bacterial Agents; Anti-Infective Agents, Local; Australia; Chlorhexidine; Community-Acquired Infections; Cross-Sectional Studies; Disease Outbreaks; Football; Fusidic Acid; Genome, Bacterial; Humans; Hygiene; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mupirocin; Ointments; Retrospective Studies; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus | 2021 |
In vitro activity and resistance rates of topical antimicrobials fusidic acid, mupirocin and ozenoxacin against skin and soft tissue infection pathogens obtained across Canada (CANWARD 2007-18).
Topics: Aminopyridines; Anti-Bacterial Agents; Canada; Fusidic Acid; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mupirocin; Quinolones; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus | 2021 |
Novel recombinant endolysin ointment with broad antimicrobial activity against methicillin-resistant Staphylococcus aureus isolated from wounds and burns.
Topics: Anti-Bacterial Agents; Bacteriophages; Burns; Fusidic Acid; Humans; Methicillin-Resistant Staphylococcus aureus; Mupirocin; N-Acetylmuramoyl-L-alanine Amidase; Ointments; Staphylococcus aureus | 2023 |